Therapeutic Asset Ratings

266 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Bbm-H901 Hemophilia B	Institute of Hematology & Blood Diseases Hospital, China	P2/3	B (60)
CIS-DIAMMINEDICHLOROPLATINUM II Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P2/3	B (60)
Blinatumomab Mixed Phenotype Acute Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P3	B (59)
Flumatinib Acute Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	B (58)
cc-5013 Acute Lymphoblastic Leukemia, Adult	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
Cyclophosphamide Newly Diagnosed	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Newly Diagnosed	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
Inno-206 Newly Diagnosed	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
Inno-206 Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
PREDNISONE TABLETS Newly Diagnosed	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
PREDNISONE TABLETS Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
Selinexor Myelodysplastic Syndrome	Institute of Hematology & Blood Diseases Hospital, China	P2	B (58)
Imatinib Acute Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	B (57)
Anti-Cd7 Car-T Hematopoietic And Lymphoid System Neoplasm	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Bortezomib Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Cytosin-Arabinosid Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
MERCAPTOPURINE ANHYDROUS Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
METHOTREXATE Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Monomethyl Fumarate ALS (Amyotrophic Lateral Sclerosis)	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
PEGASPARGASE Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
PREDNISONE TABLETS Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
(+)-VINCRISTINE Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Benadryl Inert B-cell Lymphoma Transformed Into Large B-cell Lymphoma (Excluding Richter Transformation, THRLBCL, and BL)	Institute of Hematology & Blood Diseases Hospital, China	P1/2	B (57)
Omacetaxine Childhood Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2/3	B (57)
Omacetaxine T Lymphoblastic Leukemia/Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P2/3	B (57)

Showing 76 to 100 of 266 assets

PreviousPage 4 of 11Next